NCBiotech News

Seqirus has received the go-ahead from the FDA to produce its Fluad Quadrivalent vaccine at its Holly Springs factory.

Innovation is a driving force behind the success of Eastern North Carolina's 27-county agricultural economy.

Arbiom, a Durham ag biotech company, says a new study shows its SylPro wood-derived food and feed protein ingredient demonstrated a lower climate impact than fish meal, soy protein concentrate and other protein sources.

Chiesi USA, Inc. and some 150 employees at its Cary headquarters contributed more than $980,000 worth of time and money to Triangle area charities in 2019.

North Carolina’s biopharma manufacturing market is hot at the moment – with an estimated 5,000 new jobs projected for the sector by 2025, according to a recent study.

Pappas Capital, a Durham-based investor in early-stage life sciences companies, has appointed Karen LeVert as venture partner.

Company panelists at NCBiotech's Ag Tech Professional Forum agreed on several key elements affecting their decisions about what products to pursue.

NC's life science leadership is propelled by the healthy growth of RDU.

Durham-based Mycovia Pharmaceuticals has extended its Phase 3 clinical trials of its lead drug candidate for treating recurrent yeast infections in women.

GreenLight Biosciences, headquartered in Boston, expects to double the size of its Research Triangle Park plant and data science operation over the next two years.

Raleigh-based biotechnology company Arrevus has received an Orphan Drug Designation from the FDA for its ARV-1801, an oral antibiotic to treat cystic fibrosis lung infections, .

Bob Jordan, a visionary leader who helped build the foundation for North Carolina’s global life science leadership, died today at the age of 87. 

Learn how large ag tech companies decide what to pursue when they’re looking 15 years into the future at the next Ag Tech Professional Forum Feb. 19 at the North Carolina Biotechnology Center.

The newly published 2020 edition of the “Window on the Workplace” study analysis says North Carolina's long-term commitment to biopharma workforce readiness will need to adjust and grow to meet coming demand.

Early registration for next month’s Venture Connect Summit at the Raleigh Convention Center closes on Feb. 14, offering discounted admission to the entrepreneurial showcase and networking event.